| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $44.3M | +30.6% |
| Cost of Revenue | $5.1M | +39.8% |
| Gross Profit | $39.2M | +29.5% |
| R&D Expense | $19.5M | +26.7% |
| SG&A Expense | $25.8M | +38.3% |
| Operating Income | -$27.4M | -50.4% |
| Interest Expense | $5K | +0.0% |
| Net Income | -$23.6M | -23.5% |
| EPS (Basic) | -$0.23 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.1M | -76.8% |
| Short-term Investments | $216.3M | +4.3% |
| Accounts Receivable | $11.7M | +69.5% |
| Inventory | $8.6M | +64.9% |
| Current Assets | $252.3M | -6.7% |
| Total Assets | $286.7M | +0.9% |
| Current Liabilities | $15.4M | -1.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.8M | -38.4% |
| Capital Expenditures | $18.5M | +381.9% |
| Investing Cash Flow | -$24.8M | +87.3% |
| Financing Cash Flow | $2.9M | -98.8% |
| Free Cash Flow | -$33.3M | -129.2% |
| -9.5% |
| EPS (Diluted) | -$0.23 | -9.5% |
| Total Liabilities |
| $32.7M |
| +54.0% |
| Stockholders' Equity | $254.0M | -3.4% |